Neuroinflammation in Alzheimer's disease

MT Heneka, MJ Carson, J El Khoury… - The Lancet …, 2015 - thelancet.com
Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the
neuronal compartment, but includes strong interactions with immunological mechanisms in …

Neuroplastic changes in depression: a role for the immune system

H Eyre, BT Baune - Psychoneuroendocrinology, 2012 - Elsevier
Accumulating evidence suggests that there is a rich cross-talk between the neuroimmune
system and neuroplasticity mechanisms under both physiological conditions and …

Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults

LL Carpenter, CE Gawuga, AR Tyrka, JK Lee… - …, 2010 - nature.com
Increased production of peripheral cytokines and other pro-inflammatory markers has been
linked to psychiatric disorders such as major depressive disorder and post-traumatic stress …

Clinical management of pediatric acute-onset neuropsychiatric syndrome: part I—psychiatric and behavioral interventions

M Thienemann, T Murphy, J Leckman… - Journal of child and …, 2017 - liebertpub.com
Objective: This article outlines the consensus guidelines for symptomatic treatment for
children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Pediatric …

Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system

DL Feinstein, S Kalinin, D Braun - Journal of neurochemistry, 2016 - Wiley Online Library
Aside from its roles in as a classical neurotransmitter involved in regulation of behavior,
noradrenaline (NA) has other functions in the CNS. This includes restricting the …

Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties

YJ Lee, DY Choi, YP Yun, SB Han, KW Oh… - The Journal of nutritional …, 2013 - Elsevier
Neuroinflammation has been known to play a critical role in the pathogenesis of Alzheimer's
disease (AD) through amyloidogenesis. In a previous study, we found that systemic …

Noradrenaline in alzheimer's disease: A new potential therapeutic target

IL Gutiérrez, C Dello Russo, F Novellino… - International Journal of …, 2022 - mdpi.com
A growing body of evidence demonstrates the important role of the noradrenergic system in
the pathogenesis of many neurodegenerative processes, especially Alzheimer's disease …

Locus coeruleus in the pathogenesis of Alzheimer's disease: A systematic review

Y Chen, T Chen, R Hou - Alzheimer's & Dementia …, 2022 - Wiley Online Library
The locus coeruleus (LC) is a nucleus in the brain stem producing noradrenaline. While
cognitive decline in Alzheimer's disease (AD) has primarily been related to cholinergic …

The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease

S Kalinin, PE Polak, SX Lin, AJ Sakharkar… - Neurobiology of …, 2012 - Elsevier
Damage to noradrenergic neurons in the locus coeruleus (LC) is a hallmark of Alzheimer's
disease (AD) and may contribute to disease progression. In 5xFAD transgenic mice, which …

Vagus nerve stimulation in ischemic stroke: old wine in a new bottle

PY Cai, A Bodhit, R Derequito, S Ansari… - Frontiers in …, 2014 - frontiersin.org
Vagus nerve stimulation (VNS) is currently Food and Drug Administration-approved for
treatment of both medically refractory partial-onset seizures and severe, recurrent refractory …